by

Homepage
Tags search
Neurim Pharmaceuticals

CTech 24/7

17:10 Intel CEO backs $44M round for Speedata as Israeli chipmaker targets big data bottlenecks
15:36 “Bioconvergence is not just a scientific evolution – it’s our strategic bet on the future”
15:36 “Bioconvergence is not just a scientific evolution – it’s our strategic bet on the future”
14:34 Full list of Israeli high-tech funding rounds in 2025

More stories in CTech

Neurim Pharmaceuticals

1 stories about Neurim Pharmaceuticals

About CTech Terms of Use Privacy Policy

Back to Top